Skip to content

Gross Profit at other companies

Boston Scientific logo
Boston ScientificBSX
$3.61B+12.6%
AngioDynamics logo
AngioDynamicsANGO
$41.48M+6.7%
Delcath Systems logo
Delcath SystemsDCTH
$21.26M+25.5%
Tactile Systems Technology logo
Tactile Systems TechnologyTCMD
$57.61M+27.1%
LQD
Liquidia CorporationLQDA
$1.6M+6.5%
United Therapeutics logo
United TherapeuticsUTHR

Other financials

Income statement

See full
Revenue$8.9M-2.9%
Operating income-$8.4M-14.8%
Net income$1.5M+115%
EPS (diluted)$0.03+108%

Balance sheet

See full
Cash & equivalents$56.6M+324%
Total debt$33.1M+4.4%
Total equity$12.8M+137%
Total assets$71.0M+148%

Cash flow

See full
Operating cash flow-$6.5M-44.0%
CapEx$141.0K-81.3%
Free cash flow-$6.6M-26.0%

Valuation

See full
Market cap$279.45M+49.6%
Enterprise value$255.97M+33.6%
P/S6.2×+1.0×

Profitability

See full
Gross margin85.1%-0.5pp
Operating margin-62.4%-16.8pp
Net margin-60.9%-13.4pp
FCF margin-45.2%-16.8pp

Returns & leverage

See full
Return on equity253.3%
Debt / equity2.6×
Current ratio5.8×+3.6×

Where this comes from

Calculated from TriSalus Life Sciences, Inc.’s reported figures.

The official record: TriSalus Life Sciences, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about TriSalus Life Sciences, Inc.'s gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is TriSalus Life Sciences, Inc.'s gross profit?
TriSalus Life Sciences, Inc. (TLSI) reported gross profit of $7.67M in Q1 2026.
How has TriSalus Life Sciences, Inc.'s gross profit changed year-over-year?
TriSalus Life Sciences, Inc.'s gross profit decreased by 0.0% year-over-year, from $7.67M to $7.67M.
What is the long-term trend for TriSalus Life Sciences, Inc.'s gross profit?
Over 2 years (2023 to 2025), TriSalus Life Sciences, Inc.'s gross profit has grown at a 54.9% compound annual growth rate (CAGR), from $15.91M to $38.19M.
What does gross profit mean?
Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.